Your browser doesn't support javascript.
loading
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem, E; Cervantes, A; Adam, R; Sobrero, A; Van Krieken, J H; Aderka, D; Aranda Aguilar, E; Bardelli, A; Benson, A; Bodoky, G; Ciardiello, F; D'Hoore, A; Diaz-Rubio, E; Douillard, J-Y; Ducreux, M; Falcone, A; Grothey, A; Gruenberger, T; Haustermans, K; Heinemann, V; Hoff, P; Köhne, C-H; Labianca, R; Laurent-Puig, P; Ma, B; Maughan, T; Muro, K; Normanno, N; Österlund, P; Oyen, W J G; Papamichael, D; Pentheroudakis, G; Pfeiffer, P; Price, T J; Punt, C; Ricke, J; Roth, A; Salazar, R; Scheithauer, W; Schmoll, H J; Tabernero, J; Taïeb, J; Tejpar, S; Wasan, H; Yoshino, T; Zaanan, A; Arnold, D.
Afiliação
  • Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium clinicalguidelines@esmo.org.
  • Cervantes A; Medical Oncology Department, INCLIVA University of Valencia, Valencia, Spain.
  • Adam R; Hepato-Biliary Centre, Paul Brousse Hospital, Villejuif, France.
  • Sobrero A; Medical Oncology, IRCCS San Martino Hospital, Genova, Italy.
  • Van Krieken JH; Research Institute for Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Aderka D; Division of Oncology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Aranda Aguilar E; Medical Oncology Department, University Hospital Reina Sofia, Cordoba, Spain.
  • Bardelli A; School of Medicine, University of Turin, Turin, Italy.
  • Benson A; Division of Hematology/Oncology, Northwestern Medical Group, Chicago, USA.
  • Bodoky G; Department of Oncology, St László Hospital, Budapest, Hungary.
  • Ciardiello F; Division of Medical Oncology, Seconda Università di Napoli, Naples, Italy.
  • D'Hoore A; Abdominal Surgery, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Diaz-Rubio E; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Douillard JY; Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), St Herblain.
  • Ducreux M; Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Falcone A; Department of Medical Oncology, University of Pisa, Pisa, Italy Division of Medical Oncology, Department of Oncology, University Hospital 'S. Chiara', Istituto Toscano Tumori, Pisa, Italy.
  • Grothey A; Division of Medical Oncology, Mayo Clinic, Rochester, USA.
  • Gruenberger T; Department of Surgery I, Rudolfstiftung Hospital, Vienna, Austria.
  • Haustermans K; Department of Radiation Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium.
  • Heinemann V; Comprehensive Cancer Center, University Clinic Munich, Munich, Germany.
  • Hoff P; Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil.
  • Köhne CH; Northwest German Cancer Center, University Campus Klinikum Oldenburg, Oldenburg, Germany.
  • Labianca R; Cancer Center, Ospedale Giovanni XXIII, Bergamo, Italy.
  • Laurent-Puig P; Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
  • Ma B; Department of Clinical Oncology, Prince of Wales Hospital, State Key Laboratory in Oncology in South China, Chinese University of Hong Kong, Shatin, Hong Kong.
  • Maughan T; CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Oxford, UK.
  • Muro K; Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Normanno N; Cell Biology and Biotherapy Unit, I.N.T. Fondazione G. Pascale, Napoli, Italy.
  • Österlund P; Helsinki University Central Hospital, Comprehensive Cancer Center, Helsinki, Finland Department of Oncology, University of Helsinki, Helsinki, Finland.
  • Oyen WJ; The Institute of Cancer Research and The Royal Marsden Hospital, London, UK.
  • Papamichael D; Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  • Pentheroudakis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Price TJ; Haematology and Medical Oncology Unit, Queen Elizabeth Hospital, Woodville, Australia.
  • Punt C; Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Ricke J; Department of Radiology and Nuclear Medicine, University Clinic Magdeburg, Magdeburg, Germany.
  • Roth A; Digestive Tumors Unit, Geneva University Hospitals (HUG), Geneva, Switzerland.
  • Salazar R; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Scheithauer W; Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Schmoll HJ; Department of Internal Medicine IV, University Clinic Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
  • Tabernero J; Medical Oncology Department, Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain.
  • Taïeb J; Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
  • Tejpar S; Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Wasan H; Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Zaanan A; Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
  • Arnold D; Instituto CUF de Oncologia (ICO), Lisbon, Portugal.
Ann Oncol ; 27(8): 1386-422, 2016 08.
Article em En | MEDLINE | ID: mdl-27380959
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias Colorretais / Biomarcadores Tumorais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias Colorretais / Biomarcadores Tumorais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bélgica